ATA148894A - Virusinaktivierte faktor xa-präparation - Google Patents
Virusinaktivierte faktor xa-präparationInfo
- Publication number
- ATA148894A ATA148894A AT0148894A AT148894A ATA148894A AT A148894 A ATA148894 A AT A148894A AT 0148894 A AT0148894 A AT 0148894A AT 148894 A AT148894 A AT 148894A AT A148894 A ATA148894 A AT A148894A
- Authority
- AT
- Austria
- Prior art keywords
- virusinactivated
- factor
- preparation
- virusinactivated factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6432—Coagulation factor Xa (3.4.21.6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21006—Coagulation factor Xa (3.4.21.6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4325872A DE4325872C1 (de) | 1993-08-02 | 1993-08-02 | Virusinaktivierte Faktor Xa-Präparation |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA148894A true ATA148894A (de) | 2000-10-15 |
AT407705B AT407705B (de) | 2001-05-25 |
Family
ID=6494255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0148894A AT407705B (de) | 1993-08-02 | 1994-07-27 | Virusinaktivierte faktor xa-präparation |
Country Status (6)
Country | Link |
---|---|
US (1) | US5593968A (de) |
EP (1) | EP0651054A1 (de) |
JP (1) | JPH0775572A (de) |
AT (1) | AT407705B (de) |
CA (1) | CA2129155A1 (de) |
DE (1) | DE4325872C1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4325872C1 (de) * | 1993-08-02 | 1994-08-04 | Immuno Ag | Virusinaktivierte Faktor Xa-Präparation |
US6017891A (en) * | 1994-05-06 | 2000-01-25 | Baxter Aktiengesellschaft | Stable preparation for the treatment of blood coagulation disorders |
DE4416166C2 (de) * | 1994-05-06 | 1997-11-20 | Immuno Ag | Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen |
DE19521324C1 (de) * | 1995-06-12 | 1996-10-31 | Immuno Ag | Gewebeklebstoff und Verwendung desselben als Hämostyptikum |
SI0796623T1 (en) * | 1996-03-20 | 2005-10-31 | Baxter Aktiengesellschaft | Pharmaceutical preparation for the treatment of blood coagulation disorders |
AT405517B (de) | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-deletionsmutanten und analoge davon |
AT405516B (de) | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-analoge mit modifizierter proteasespaltstelle |
DE19710190A1 (de) * | 1997-03-12 | 1998-09-17 | Immuno Ag | Aktivierter Vitamin K-abhängiger Blutfaktor und Verfahren zu dessen Herstellung |
AT408613B (de) * | 1998-06-17 | 2002-01-25 | Immuno Ag | Pharmazeutisches faktor vii-präparat |
AT410216B (de) | 1999-08-10 | 2003-03-25 | Baxter Ag | Faktor x-analogon mit verbesserter aktivierbarkeit |
JP4676585B2 (ja) | 1999-12-24 | 2011-04-27 | 一般財団法人化学及血清療法研究所 | 血液凝固異常に基づく疾患の治療・予防用医薬組成物 |
US7671013B2 (en) | 2003-04-03 | 2010-03-02 | Canadian Blood Services, Inc. | Coagulation proteins, coagulation-anticoagulation protein complexes, derivatives thereof and their uses |
WO2004087198A1 (en) * | 2003-04-03 | 2004-10-14 | Canadian Blood Services | Use of coagulation proteins to lyse clots |
DE102006008613A1 (de) | 2006-02-24 | 2007-08-30 | Dade Behring Marburg Gmbh | Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung |
US9956272B2 (en) * | 2007-05-30 | 2018-05-01 | Bio Products Laboratory Limited | Methods for preparing factor X, activated factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2916711A1 (de) * | 1979-04-25 | 1980-11-06 | Behringwerke Ag | Blutgerinnungsfaktoren und verfahren zu ihrer herstellung |
US4495278A (en) * | 1981-04-27 | 1985-01-22 | Baxter Travenol Laboratories, Inc. | Process for making novel blood clotting enzyme compositions |
ATE36457T1 (de) * | 1983-05-02 | 1988-09-15 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen krankheitserregern. |
US4501731A (en) * | 1983-06-27 | 1985-02-26 | Tishkoff Garson H | Treatment of disparate bleeding disorders with factor X zymogen |
US4721618A (en) * | 1983-06-27 | 1988-01-26 | Queen's University At Kingston | Method for controlling bleeding |
US4536392A (en) * | 1983-06-27 | 1985-08-20 | Queen's University At Kingston | Method for controlling hemophilia in mammals |
US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
AT389815B (de) * | 1984-03-09 | 1990-02-12 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten |
US4721572A (en) * | 1985-07-12 | 1988-01-26 | Miles Laboratories, Inc. | Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices |
DE4142908C2 (de) * | 1991-12-24 | 1994-02-10 | Octapharma Ag Glarus | Verfahren zur Herstellung eines virusinaktivierten Prothrombinkomplex-Konzentrats (PPSB) |
AT399818B (de) * | 1992-04-24 | 1995-07-25 | Immuno Ag | Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation |
DE4325872C1 (de) * | 1993-08-02 | 1994-08-04 | Immuno Ag | Virusinaktivierte Faktor Xa-Präparation |
-
1993
- 1993-08-02 DE DE4325872A patent/DE4325872C1/de not_active Expired - Fee Related
-
1994
- 1994-07-27 AT AT0148894A patent/AT407705B/de not_active IP Right Cessation
- 1994-07-29 CA CA002129155A patent/CA2129155A1/en not_active Abandoned
- 1994-08-02 EP EP94112073A patent/EP0651054A1/de not_active Ceased
- 1994-08-02 US US08/285,040 patent/US5593968A/en not_active Expired - Fee Related
- 1994-08-02 JP JP6181328A patent/JPH0775572A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0651054A1 (de) | 1995-05-03 |
JPH0775572A (ja) | 1995-03-20 |
US5593968A (en) | 1997-01-14 |
CA2129155A1 (en) | 1995-02-03 |
DE4325872C1 (de) | 1994-08-04 |
AT407705B (de) | 2001-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO971878L (no) | Modifiert faktor VII | |
NO985668D0 (no) | Modifisert faktor VII | |
ATE324454T1 (de) | Faktor x-analoge mit modifizierter proteasespaltstelle | |
DK0950678T3 (da) | Alifatiske-aromatiske copolyestere | |
DE69620292D1 (de) | Copolyester Zusammensetzung | |
DE69403914D1 (de) | Objektorientiertes midisystem | |
DE59108836D1 (de) | Reaktive Zerstäubungsvorrichtung | |
ATA148894A (de) | Virusinaktivierte faktor xa-präparation | |
FI943458A0 (fi) | Aktivoitu tekijä XIII | |
DE69406617D1 (de) | Schalter | |
NO971279D0 (no) | Kopolyestere | |
DE59407422D1 (de) | Gerippestruktur | |
NO975605D0 (no) | Faktor X | |
ATA243193A (de) | Fassade | |
DE69420041D1 (de) | Store | |
DE69220306D1 (de) | Faktor Xa-Linker DNA | |
FI931805A0 (fi) | Form foer framstaellning av betongelement | |
DK103393D0 (da) | Praeparat | |
FI930419A0 (fi) | Foerfarande foer kompensering av maetfel i en lutningsindikator | |
ATA901190A (de) | Aufgereinigter ziliärer neurotropher faktor | |
KR950010759U (ko) | 카운터용 판재의 구조 | |
DE4090006T1 (de) | Aufgereinigter ziliaerer neurotropher faktor | |
DK117693A (da) | Tandstikker | |
LV5410A3 (lv) | Sujamais materials | |
KR940021883U (ko) | 우편함 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |